FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
CNBC - 2024-04-26T11:02:36.000Z

The agency greenlighted the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B. Read this story